Press release
Diabeloop and SOOIL launch DBLG1 with Dana-i Pump in Germany, Distributed by Mediq
Diabeloop announces Commercial Availability of DBLG1 with Dana-i Insulin Pump in Germany.
Grenoble, FRANCE - July 9th, 2025 - Diabeloop is pleased to announce the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from SOOIL in Germany.
The system is distributed through Mediq, a leading provider in the European diabetes market. Mediq has been appointed as the exclusive distributor for the DBLG1 system and the Dana-i pump by SOOIL.
The Dana-i is the latest version of the trusted and user-friendly Dana pump, making it an excellent match for Diabeloop's DBLG1 self-learning algorithm. Mediq will support the German rollout with high-quality customer service and training.
The initial launch phase will be for patients already using a Dexcom G6 CGM.
"We are committed to offering more choices to people with diabetes," said Cecile Ferracci, Chief Commercial Officer of Diabeloop. "Thanks to this partnership with SOOIL-an outcome of our interoperability strategy-we are proud to now offer three options to patients in Germany: DBLG1 with Accu-Chek Insight (Roche), DBLG1 with Kaleido (Vicentra), and DBLG1 with Dana-i. All three systems are integrated with the Dexcom G6 continuous glucose monitor."
"Our next step in Europe is the upcoming launch of DBLG2, the version available on patients' smartphones, paired with the Dexcom G7."
For more information, visit dbl-diabetes.de [http://dbl-diabetes.de/] or contact Mediq Germany.
About Diabeloop
Diabeloop has achieved MDR certification for the DBLG1 system with Vicentra's Kaleido pump at the end of 2023. This was the first generation of the MDR approved DBLG1 system and is a significant achievement resulting from all the efforts made by the company to guarantee quality standards and regulatory requirements of the highest level.
Over 2024 and Q1 2025, Diabeloop has completed a Series D financing round of 24.6m with the historical investors (LBO France, Adag, Cemag Invest, Promontoire, Supernova Invest, UI Investissement, Odyssee Venture, Terumo Corporation, Innovacom) to support its sustained growth strategy and its high-impact projects.
Today, Diabeloop brings together the personalities, passions and skills of talented people who work daily with passion and commitment to improve the quality of life of each person living with diabetes.
Contact
Cecile Ferracci, Chief Commercial Officer for Diabeloop
cecile@diabeloop.fr [mailto:cecile@diabeloop.fr]
Media Contact
Company Name: Diabeloop
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=diabeloop-and-sooil-launch-dblg1-with-danai-pump-in-germany-distributed-by-mediq]
Country: France
Website: http://diabeloop.fr
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabeloop and SOOIL launch DBLG1 with Dana-i Pump in Germany, Distributed by Mediq here
News-ID: 4098433 • Views: …
More Releases from Getnews
New Research Finds 80% of Major AI Platforms Non-Compliant with EU Regulatory St …
First Independent Industry-Wide Assessment Reveals Systemic Governance Gaps Across Enterprise AI Vendors; Estimated Aggregate Exposure Exceeds 500 Billion
SANDIEGO, CA - Diplomacy AI today released the Q1 Special Edition 2026 Janus AI Risk Index, the first independent industry-wide assessment of AI governance readiness across 20 major enterprise platforms. The findings reveal that 80% of assessed vendors exhibit material regulatory compliance deficiencies, with significant implications for insurance underwriting, enterprise procurement, and vendor…
MyTurkishCharter Presents 2026 Luxury Yacht Charters to Turkey's Ancient Cities, …
My Turkish Charter, operated by DMA Yachting, announces new 2026 guidance designed to help travelers plan incredible luxury yacht charters in Turkey, emphasizing what makes the region unique: the combination of high-end yachting and remarkably easy access to ancient cities, coastal ruins, and UNESCO sites. Many of these locations sit directly on the shoreline or can only be reached by boat, offering experiences that are not available through land-based travel.
Image:…
DBLG2 from Diabeloop Becomes the First Automated Insulin Delivery (AID) Cleared …
Image: https://www.globalnewslines.com/uploads/2026/01/1768996834.jpg
Although not announcing meals might lead to a lower glycemic control, this offers choice to the patients in managing diabetes in their everyday life. This marks a major step forward in the evolution of automated insulin delivery and a meaningful milestone toward a fully closed-loop system.
Grenoble, France - January 21, 2026 - Diabeloop, a pioneer in therapeutic artificial intelligence, announces that its DBLG2 AID has become the first solution…
Hu Jiaqi's Core Thought on Humanity's Issues
In an era when human civilization is mired in existential crises like runaway technological advancement, ecological collapse and geopolitical conflicts, Hu Jiaqi, after more than four decades of dedicated intellectual exploration, has constructed a comprehensive academic framework centered on the ultimate goal of "the holistic survival and universal well-being of humanity." Grounded in a realistic understanding of human nature, his thought system rests upon three core principles and follows a…
More Releases for Diabeloop
Diabeloop and Sequel Med Tech Enter Partnership to Integrate FDA-Cleared DBLG2 i …
Image: https://www.globalnewslines.com/uploads/2026/01/1768400646.jpg
Companies anticipate product readiness by end of 2026 and launch in the US in 2027. Integration will give people with diabetes more choice in how they manage their diabetes care with twiist.
GRENOBLE, France & Manchester, New Hampshire, U.S. - January 14, 2026 - Following the U.S. Food and Drug Administration (FDA) 510(k) clearance granted December 18, 2025 for DBLG2 as an Interoperable Automated Glycemic Controller (iAGC), Diabeloop and Sequel…
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery …
Image: https://www.globalnewslines.com/uploads/2026/01/1767910005.jpg
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for automated insulin delivery, with the validation of its DBLG2 algorithm and its predetermined Change Control Plan (PCCP) by the FDA.
GRENOBLE, France - January 8th, 2026 - Diabeloop announces today that it has received 510(k) clearance from the U.S. Food…
Implantable Insulin Pump Market Size, Growth Analysis 2031 by Key Vendors- Apex …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Research analysis, the global Implantable Insulin Pump Market size is reached a valuation of USD 3.46 Billion in 2023, with projections to achieve USD 6.91 Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑 9.03% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
What is the current market outlook for the implantable insulin pump industry?
The implantable insulin pump market is experiencing significant growth, driven by the increasing prevalence of diabetes globally,…
Diabeloop study reveals significative gender differences in insulin requirements …
Image: https://www.getnews.info/wp-content/uploads/2024/07/1721065120.jpeg
Grenoble, France - 16 July, 2024 - A groundbreaking real-world study involving over 9,000 adults with type 1 diabetes has uncovered important differences between males and females in insulin requirements. The study, conducted across Europe, utilized data from patients using the Diabeloop Generation 1 (DBLG1) hybrid closed-loop insulin delivery device and was published last month in the Journal of Diabetes Science and Technology*.
The study included 9,036 participants across multiple…
Non-Invasive Drug Delivery Market Latest Rising Trend & Forecast to 2027 - Lead …
A new market report by The Insight Partners on the Non-Invasive Drug Delivery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report…
Artificial Pancreas Systems Market worth $175.98 Million by 2026| Key Players-Me …
Global Artificial Pancreas Systems Market is expected to rise to an estimated value of USD 175.98 million by 2026 registering a substantial CAGR in the forecast period of 2019-2026. This rise in the value of the market can be attributed to the rising demand of remote monitoring applications, increasing demand for home care setting devices and government initiatives in clinical research.
The study helps in identifying and tracking emerging players in…
